D86.87 ICD-10-CM Code: Sarcoid myositis
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) / Certain disorders involving the immune mechanism (D80-D89)
D86.87
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceSarcoid myositis
Inflammation of the muscles caused by sarcoidosis, leading to muscle weakness, pain, and potential loss of function.

Buddy Insight
Sarcoid myositis is a rare but clinically significant manifestation of sarcoidosis involving granulomatous inflammation of skeletal muscle.
CMS-HCC V28
MappedHCC 93
RAF 0.175
CMS-HCC V24
00
RAF 0
ACA/HHS
00
RAF 0
ESRD/PACE
00
RAF 0
RXHCC
00
RAF 0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for D86.87 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for D86.87 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for D86.87 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for D86.87 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for D86.87 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for D86.87 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for D86.87 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is D86.87 an HCC code?
Yes. D86.87 maps to Rheumatoid Arthritis and Inflammatory Connective Tissue Disease under the CMS-HCC V28 risk adjustment model.
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for D86.87
For D86.87to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed D86.87 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
D86.87 is the ICD-10-CM diagnosis code for sarcoid myositis. Inflammation of the muscles caused by sarcoidosis, leading to muscle weakness, pain, and potential loss of function. D86.87 sits in the ICD-10-CM chapter for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (d50-d89), within the section covering certain disorders involving the immune mechanism (d80-d89).
Under the CMS-HCC V28 risk adjustment model, D86.87 maps to Rheumatoid Arthritis and Inflammatory Connective Tissue Disease (HCC 93) with a community, non-dual, aged base RAF weight of 0.175. D86.87 was not retained as a payment HCC under the older V24 model, so V28 introduced or recategorized it during the 2024–2026 phase-in. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Document the location and severity of muscle involvement. Because D86.87 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for D86.87 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Document the location and severity of muscle involvement
- •Differentiate from other myositis causes by confirming sarcoidosis etiology in documentation
Clinical Significance
Sarcoid myositis is a rare but clinically significant manifestation of sarcoidosis involving granulomatous inflammation of skeletal muscle. It can present as acute myopathy with proximal muscle weakness, chronic progressive myopathy, or incidentally discovered nodular muscle lesions. Though uncommon, it can cause significant functional impairment and may mimic other inflammatory myopathies, requiring careful diagnostic workup.
Documentation Requirements
- ✓Documentation must confirm sarcoidosis as the cause of the myositis, ideally with muscle biopsy showing non-caseating granulomas.
- ✓The provider should record presenting symptoms (weakness, pain, functional limitations), elevated muscle enzymes (creatine kinase), EMG/MRI findings, and treatment plan.
- ✓The relationship between the myositis and underlying sarcoidosis must be clearly stated.
Commonly Confused Codes
- •M60.9 (Myositis, unspecified) should not be used when sarcoidosis is the documented cause.
- •M33.20 (Polymyositis without myopathy) and M33.22 (Polymyositis with myopathy) are used for idiopathic inflammatory myopathies, not sarcoid-related muscle inflammation.
- •D86.89 (Sarcoidosis of other sites) is less specific and should not be used when D86.87 is available.